ARTICLE SUMMARY:
Having raised a half billion dollars in venture financing, Imperative Care is building a platform that can deliver sustainable hypergrowth in the stroke market with a new approach to thrombectomy and a model that marries new technologies such as AI and digital health with a novel service component.
More so than even cancer or heart disease, in both its acuity and unpredictability, stroke could be argued to be one of the most challenging and dire of health problems. Less than a decade after its launch, Campbell, CA-based Imperative Care is redefining traditional approaches to stroke through a multifaceted program that in addition to conventional medical device tools, incorporates advanced technology such as AI/digital and robotics to create a platform designed to achieve not just a high rate of growth, but a sustainable level of hypergrowth that in its early launch has impressed both stroke physicians and investors. Imperative Care is one of a handful of medtech start-ups to have raised recent rounds of capital greater than $100 million. For Imperative Care CEO Fred Khosravi, a medtech veteran, the company’s success represents both a new chapter in medical devices, “Medtech 3.0,” if you will, and, in a way, a return to the halcyon days of the very beginning of today’s medtech industry.
